Difference between revisions of "Akira Pharmaceutical Supplies"
Line 41: | Line 41: | ||
===Enemies=== | ===Enemies=== | ||
Akira Pharmaceutical Supplies has made several rivals in the medical field, most of which are due to their treatments for chronic conditions. | Akira Pharmaceutical Supplies has made several rivals in the medical field, most of which are due to their treatments for chronic conditions. | ||
==Current Status== | ==Current Status== |
Latest revision as of 21:43, 4 December 2023
"Your health is our goal." | |
---|---|
Connection | 3 |
Type | A ranked Megacorperation |
Player May Join | No No |
Health | Growing |
Area of Operation | Ucas and East Asia, Based in Ontario |
Faction Information
Summary
Akira Pharmaceutical supplies is a drug company that earned its A ranking 13 years ago, due to breakthroughs on certain treatment drugs for the chronically ill. Away from private eye, they gained most of their research from gruesome experimentation on infected and S.U.R.G.E.D. individuals. They are ruthless in their business practices, and have little care for metahuman lives unless they are paying them.
Goals
-Get an AA rank
-Develop a cure for long-term symptoms of VITAS infection.
-Figure out a way to improve upon savior nanites.
-(Personal goal of leader) find his missing son.
Major Locations
Ontario, UCAS
Leaders
John Akira, the CEO of the company.
Eric Akira, John Akira's son, and one of the top shareholders in the company.
Sirin Termore, the head of operations in Seattle.
Background
Allies
Akira Pharmaceutical Supplies is associated with several human supremist groups, notably having helped fund Humanis under the table.
Enemies
Akira Pharmaceutical Supplies has made several rivals in the medical field, most of which are due to their treatments for chronic conditions.
Current Status
Health Summary
Akira Pharmaceutical Supplies is still a growing company, and shows no sign of slowing down at the moment, despite attempts from rivals.
Members
Contacts
None
Narrative Significant Runs
Name | GM | Metaplot | Date of Run |
---|---|---|---|
Redmond Retroviral Retrieval | Lotus | 16 November 2084 |